Biomet Hip Lawsuit

Orthopedics manufacturer, Zimmer Biomet may be facing thousands of Biomet hip lawsuits filed by patients who were harmed by the M2a Magnum hip device and other artificial hip joint products.

Biomet Hip LawsuitHip replacements can help a person regain mobility and live pain-free, but they can also have the opposite effect and turn a tolerable health issue into something devastating. Much of the risk is based on the type of hip replacement a patient and his or her doctor choose. The Biomet M2a Magnum Hip System is one that is under scrutiny for causing a number of health issues. It is marketed for its enhanced durability, but research has shown this type of replacement actually carries a great deal of risk for failure.

The M2a Magnum is not the exception when it comes to risks for consumers. Many metal-on-metal replacements have caused pain and injury for users. Information published in the British Medical Journal showed metal-on-metal options appear to be increasingly less effective as a solution for hip replacement. Additional research from the US Food and Drug Administration reported more than 12,000 issues were reported with metal-on-metal devices in 2011, which was nearly double the number reported with other devices.

Biomet M2a Magnum Hip Replacements

Most people assume having a hip replacement is a “set it and forget it” procedure. Unfortunately, many with Biomet hip replacements must undergo revision surgery after the initial procedure.

The main reason these implants are failing is because the metal-on-metal component of the replacement causes friction that leads to shards of debris loosening and damaging the surrounding tissue. This causes unbearable pain and eventually requires follow-up surgery. For many, this does not solve the problem. There have been so many occasions to remove or replace this type of implant, numerous safety alerts have been issued concerning the brand.

Litigation Status

Faced with costly follow-up surgery and little hope of full recovery, some patients are left with no choice but to file a lawsuit against Biomet. As of November 2013, more than 725 federal lawsuits had been filed against the company concerning the M2a implant.

As a result of the numerous suits filed in federal court, a federal judicial panel chose to centralize the proceedings and combined eight pending cases and all future cases to the US District Court for the Northern District of Indiana. This court was chosen because Biomet, Inc. is headquartered in the state, providing easier access to witnesses and documents associated with the case.

A hearing has already been held concerning the scientific and technical issues relevant to the proceedings and Biomet employees have shared testimony. Most recently, plaintiffs’ lawyers in the Indiana suit agreed to the appointment of a special master in the case because it would facilitate the resolution of certain discovery issues in the Biomet hip replacement litigation.

Defendants named in the case include Biomet, Inc. and various Biomet business units, including Biomet Orthopedics, LLC; Biomet Fair Lawn, LLC; Biomet Manufacturing Corp.; and Biomet U.S. Reconstruction, LLC (collectively “Biomet”).

It is expected additional plaintiffs will be added to the cases in Indiana and a centralized action might also occur in other states where suits have been filed. New Jersey is currently dealing with several filings at the state level and has combined previous hip implant litigation into a centralized case in the past.

Why Should You File a Biomet Hip Lawsuit Regarding the Biomet M2a Magnum Hip System?

As stated above, the metal-on-metal components in the Biomet M2 Magnum system create a fracturing of the metal material that damages the tissue in the user’s body. Plaintiffs in the lawsuits believe Biomet was aware of these risks, but failed to make the information public.

If you or a loved one has been affected by a Biomet hip replacement and you believe:

  • Biomet failed to exercise reasonable care in the design, manufacture, and testing of their system
  • Biomet falsely claimed the M2a Magnum system was safer and more reliable than other options
  • Biomet failed to disclose the risks for severe injury and permanent damage from the M2a system
  • Biomet failed to provide health care professionals with adequate information about their system

Filing a lawsuit can result in compensation for injuries, pain, and suffering.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA. 

View Sources